Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase
Oncostellae has raised $330K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Oncostellae's investors include Inveready, Centre for the Development of Industrial Technology (CDTI), CDTI Innovación's INNVIERTE program, Capital Cell, Xesgalicia.
Oncostellae is headquartered in Orense, Spain.
Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase
Oncostellae is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncostellae — Funding & Investors." VCBacked, September 17, 2025, https://www.vcbacked.co/company/oncostellae. Accessed October 2, 2026.
VCBacked. (2025). Oncostellae — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/oncostellae
{{cite web |title=Oncostellae — Funding & Investors |url=https://www.vcbacked.co/company/oncostellae |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated